Source: International Congress 2015 – Outcomes of lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
RIGAUD Matthieu (Sete, France), Matthieu Rigaud, Claire Dromer. Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study. Eur Respir J 2015; 46: Suppl. 59, 4553

Member's Comments

No comment yet.

Related content which might interest you: The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Evaluation of the biological effects of atorvastatin in lung transplant recipients Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 The effect of everolimus on lung function and renal status in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study. Source: Virtual Congress 2021 – Thoracic ultrasound: future applications and current evidence Year: 2021 Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms Year: 2016 LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX) Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003 Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008 Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab? Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004 Comprehensive pulmonary rehabilitation (PR) decreases frailty in lung transplant recipients – a prospective observational study Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2021 A single-season prospective study of respiratory viral infections in lung transplant recipients Source: Eur Respir J 2006; 28: 131-137 Year: 2006 Initial treatment with CsA-AZA versus FK506-MPA: Comparison of early outcomes after lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx) Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Extracorporeal photoapheresis in the treatment of chronic lung rejection: preliminary clinical and immunological results on a small cohort of lung recipients Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008 The use of mTOR inhibitors is associated with improved survival in lung transplant recipients Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003